QR kód

Prediction of Oncotype Dx recurrence score using clinical parameters: A comparison of available tools and a simple predictor based on grade and progesterone receptor

Objective/Background: The Oncotype Dx test is a genomic test currently used in clinical practice to predict the risk of disease recurrence in estrogen receptor (ER)-positive, HER2-negative breast cancer patients with axillary lymph node-negative or micrometastatic disease. The test is one of several...

Celý popis

Uloženo v:
Hlavní autoři: Stephane Thibodeau, Ioannis A. Voutsadakis
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Medknow Publications 2019-01-01
Edice:Hematology/Oncology and Stem Cell Therapy
Témata:
breast cancer
chemotherapy
oncotype dx test
predictive tools
recurrence prediction
On-line přístup:https://journals.lww.com/10.1016/j.hemonc.2019.02.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky